SUPERNUS PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2024.
  • Supernus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $7.63M, a 18.4% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $27.8M, a 3.72% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $27.8M, a 3.72% increase from 2023.
  • Supernus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $26.8M, a 52.3% increase from 2022.
  • Supernus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.6M, a 1.91% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $27.8M +$996K +3.72% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $26.8M +$9.19M +52.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $17.6M -$342K -1.91% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $17.9M +$1.35M +8.15% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $16.6M +$1.72M +11.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $14.8M +$3.56M +31.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
2018 $11.3M +$2.86M +33.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $8.43M +$2.51M +42.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $5.93M +$1.84M +44.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $4.09M +$1.23M +43.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $2.86M +$944K +49.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $1.91M +$1.47M +332% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 $443K +$525K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$82K -$379K -128% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 $297K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.